Applied Therapeutics, Inc.

APLT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$105,624-$119,763-$82,508-$105,584
Dep. & Amort.$425$354$443$415
Deferred Tax$0$0$0$0
Stock-Based Comp.$13,467$7,360$9,603$11,177
Change in WC$2,520-$1,441-$8,844$3,668
Other Non-Cash$4,907$58,317$3,213-$404
Operating Cash Flow-$84,305-$55,173-$78,093-$90,728
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$64,218-$121,589
Inv. Sales/Matur.$0$13,872$77,388$134,022
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$13,872$13,170$12,433
Financing Activities
Debt Repay.-$311-$1,858-$3,273-$4,718
Stock Issued$104,748$64,514$27,811$74,421
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$9,368$11,886$3,154$5,014
Financing Cash Flow$113,805$74,542$27,692$74,717
Forex Effect$0$0$0$0
Net Chg. in Cash$29,500$33,241-$37,231-$3,578
Supplemental Information
Beg. Cash$49,898$16,657$53,888$57,466
End Cash$79,398$49,898$16,657$53,888
Free Cash Flow-$84,305-$55,173-$78,093-$90,728